🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Newest paper from group Alexandra Trkola is out in npj Journals. Maliqi et al. offer with DANA an innovative in vitro tool that reveals antigenic features of stabilized HIV trimers that complements in vivo immunogenicity testing of HIV vaccine candidates. doi.org/10.1038/s41541…

Fantastic collaboration with Tom Loosli Roger Kouyos Richard Lessells Jonathan Sterne Huldrych Günthard caroline ISPM Bern University of Zurich krisp University of Bristol IeDEA-SA 5/5

Laura Waters Jose R Arribas Paul Sax The Lancet HIV EACS Ty Jose R Arribas for highlighting our MA during #EACS2023 and to authors of #RCT for their generosity in sharing individual data in the hope to advance science Esteban Martinez 🇺🇦 Huldrych Günthard Bart Rijnders It is not that common!

Grateful for the EACS award 🏆 at #EACS2023! This honor isn't just mine; it's all of ours. Big thanks to everyone who's been and continues to be a part of supporting those living with HIV. Together, we can create a world free of stigma. 🌍 #LivingFreeWithHIV EACS

Very proud to welcome the European AIDS community in Paris as co-chair with Jean-michel Molina of the 2025 #EACS2025 conference ! I can tell you that we will shape an amazing programme for the conference and… outside the conference 😎EACS

Looking forward to continue our work on bNabs and to conduct innovative vaccination studies together with colleagues from South Africa within the SHCS and CAPRISA Penny Moore Alexandra Trkola @HivSwiss

#Resistenzen können #HIV-Wirkstoffe unbrauchbar machen. Ein Forscherteam von #USZ, Universität Bern und der University of KwaZulu-Natal hat beim Wirkstoff DTG Risiko und Ursachen von Resistenzen untersucht. Huldrych Günthard @HivSwiss Tom Loosli Roger Kouyos Matthias Egger usz.ch/resistenz-gege…

Kürzlich hat doch die NZZ geschwärmt, wie toll Innerrhödler seien, die selten eine Ärztin/Arzt aufsuchten und denen familiäre Fürsorge, Kohlwickel und Naturheilsprays noch was bedeute und deshalb der Kanton tiefe Gesundheitskosten verzeichne. Tja 👇.

Seit 1988 trägt die Swiss HIV Cohort Study (#SHCS) massgeblich zu mehr Wissen, zur besseren Behandlung und Bekämpfung von #HIV in der Schweiz und weltweit bei. usz.ch/schweizerische… @HivSwiss Dominique Laurent Braun Huldrych Günthard

In sieben Jahren keine Ansteckungen: Wie lässt sich das Ziel des Bundes erreichen? Wie sinnvoll sind präventive HIV-Medikamente? Infektiologe Huldrych Günthard zu den ambitionierten Plänen. tagesanzeiger.ch/aids-am-ende-h…

Looking for a Postdoc in Computational HIV Vaccinology, with a robust quantitative background for a cutting-edge project at the intersection of bioinformatics, virology & HIV immunology. Collaboration btw groups of Alexandra Trkola , Roger Kouyos , Huldrych Günthard eth-gethired.ch/en/jobs/detail…

Just great that the Swiss HIV Cohort Study is part of this highly innovative project! #HivSwiss

Great that after more than 35 years we have a cohort profile about of this amazing project: the Swiss Mother and Child HIV Cohort Study, (MoCHiV), embedded in the Swiss HIV Cohort Study (SHCS)! Thanks to all for the great work but foremost all women/children for participation!

🔥🔥Just published: New 2024 IAS–USA #HIV Antiretroviral Guidelines in JAMA Guidelines are free! 🔥🔥 Honored to be part of this effort. jamanetwork.com/journals/jama/…

LLV needs attention. Not easy however to find the perfect approach beyond close monitoring. Interestingly, fraction of LLV declines after InSTIs were introduced, suggesting that at least part of it is relevant viral replication.

Happy to see one paper of the Swiss HIV Cohort Study among the five best ones selected in CID!

Super excited to share our new research published in PNAS, where we demonstrate that probiotic treatments could be more effective than antibiotics for decolonizing nasal pathobionts like Staphylococcus aureus and Streptococcus pneumoniae! 🦠 We developed a novel framework

Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical Data ✅ Just Accepted 🔗 bit.ly/3E1YbQk

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance ✅ Just Accepted ✍️ IAS–USA 🔗 bit.ly/42pc4QB

New online! Phylogenetics and molecular evolution to understand and curb the HIV pandemic nature.com/articles/s4157…